Get started
Author

Jeremy P. C. Steele

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
2008 · Martin F Muers, Richard J Stephens, et al. · The Lancet · 260
PDF
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
2018 · Ian Woolhouse, Lesley Bishop, et al. · Thorax · 220
PDF
Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma
2016 · Peter W. Szlosarek, Jeremy P. Steele, et al. · JAMA Oncology · 203
PDF
Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma
2000 · Jeremy P. C. Steele, Jonathan Shamash, et al. · Journal of Clinical Oncology · 203
In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion
2006 · Peter W. Szlosarek, Astero Klabatsa, et al. · Clinical Cancer Research · 181
Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma
2012 · Loïc Lang-Lazdunski, Andrea Bille, et al. · Journal of Thoracic Oncology · 165
PDF
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
2008 · Justin Stebbing, Thomas Powles, et al. · Lung Cancer · 153
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial
2024 · Eric Lim, David Waller, et al. · The Lancet Respiratory Medicine · 132
Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
2017 · Emma Beddowes, James Spicer, et al. · Journal of Clinical Oncology · 121
Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials
2004 · Dean A. Fennell, Amit Parmar, et al. · Journal of Clinical Oncology · 109
Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: A 10-year experience
2014 · Loïc Lang-Lazdunski, Andrea Bille, et al. · Journal of Thoracic and Cardiovascular Surgery · 95
PDF
Prognostic factors in mesothelioma
2005 · Jeremy P.C. Steele, Astero Klabatsa, et al. · Lung Cancer · 63
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
2024 · Peter W. Szlosarek, Benjamin C. Creelan, et al. · JAMA Oncology · 61
PDF
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndrome
2023 · Fiona Lalloo, Anju Kulkarni, et al. · European Journal of Human Genetics · 59
Chemotherapy options and new advances in malignant pleural mesothelioma
2005 · J.P.C. Steele, A. Klabatsa · Annals of Oncology · 59
PDF
Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)
2005 · A. Klabatsa, M.T. Sheaff, et al. · Lung Cancer · 53
Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma
2011 · Loïc Lang-Lazdunski, Andrea Bille, et al. · Journal of Thoracic Oncology · 52
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
2004 · Dean A. Fennell, Jeremy P. C. Steele, et al. · Lung Cancer · 47
Efficacy and safety of first‐ or second‐line irinotecan, cisplatin, and mitomycin in mesothelioma
2006 · Dean A. Fennell, Jeremy P.C. Steele, et al. · Cancer · 46
BTS guideline for the investigation and management of malignant pleural mesothelioma
2018 · Ian Woolhouse, Lesley Bishop, et al. · BMJ Open Respiratory Research · 39
PDF
Expert Consensus on the Management of Erlotinib-Associated Cutaneous Toxicity in the U.K.
2009 · Nicholas Thatcher, Marianne Nicolson, et al. · The Oncologist · 38
PDF
Prognostic factors in mesothelioma
2002 · Jeremy P.C. Steele · Seminars in Oncology · 38
Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
2012 · Jaine K. Blayney, Giovanni L. Ceresoli, et al. · European Journal of Cancer · 36
PDF
A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.
2021 · Dean Anthony Fennell, Angela Claire Casbard, et al. · Journal of Clinical Oncology · 35
Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma
2001 · J.P.C. Steele, C.A. O’Doherty, et al. · Annals of Oncology · 35
PDF
Works count: 75
Citation count: 2,823
H-index: 27
I10-index: 37
Year
Topic
Type